NovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call Transcript April 24, 2025
NovoCure Limited beats earnings expectations. Reported EPS is $-0.31, expectations were $-0.47.
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Limited First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during the session, you’ll need to press star 11...
